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Abstract
Background: Motor impairment after stroke interferes with performance of everyday activities. Upper limb spasticity
may further disrupt the movement patterns that enable optimal function; however, the specific features of these
altered movement patterns, which differentiate individuals with and without spasticity, have not been fully identified.
This study aimed to characterize the kinematic and proprioceptive deficits of individuals with upper limb spasticity after
stroke using the Kinarm robotic exoskeleton.
Methods: Upper limb function was characterized using two tasks: Visually Guided Reaching, in which participants
moved the limb from a central target to 1 of 4 or 1 of 8 outer targets when cued (measuring reaching function) and
Arm Position Matching, in which participants moved the less-affected arm to mirror match the position of the affected
arm (measuring proprioception), which was passively moved to 1 of 4 or 1 of 9 different positions. Comparisons were
made between individuals with (n = 35) and without (n = 35) upper limb post-stroke spasticity.
Results: Statistically significant differences in affected limb performance between groups were observed in reaching-
specific measures characterizing movement time and movement speed, as well as an overall metric for the Visually
Guided Reaching task. While both groups demonstrated deficits in proprioception compared to normative values, no
differences were observed between groups. Modified Ashworth Scale score was significantly correlated with these
same measures.
Conclusions: The findings indicate that individuals with spasticity experience greater deficits in temporal features of
movement while reaching, but not in proprioception in comparison to individuals with post-stroke motor impairment
without spasticity. Temporal features of movement can be potential targets for rehabilitation in individuals with upper
limb spasticity after stroke.
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Background
Sensorimotor impairments after stroke result in func-
tional deficits that are targets for neurorehabilitation in-
terventions. Important to effective implementation of
these interventions is an understanding of the character-
istics of the specific deficits that persist after stroke.
Better alignment between these specific deficits and the
rehabilitation approach may enhance opportunities for
recovery after stroke.
The impairments that manifest after stroke generally
reflect abnormal synergy patterns or reduced (i.e. weak-
ness/paresis) or exaggerated (i.e. spasticity) motor activ-
ity. Indeed, individuals with spasticity, defined as a
motor disorder characterized by a velocity-dependent
increase in stretch reflexes resulting from hyperexcitabil-
ity of the stretch reflex [1], can demonstrate involuntary
activation of muscles [2], soft-tissue contracture, and
muscle overactivity [3]. Reductions in spasticity can
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increase use of the affected limb [4] and improve functional
outcomes [5–8], though the mechanism of improvement
(i.e. enhanced proprioception, normalized kinematic pat-
terns) is not well established. Determining the features (i.e.
components) of movement that are impaired in individuals
with spasticity may subsequently identify potential targets
for therapeutic interventions, which may facilitate recovery.
As a first step, it is necessary to characterize sensorimotor
impairment in individuals with post-stroke spasticity during
active functional tasks.
A recent systematic review reported that a moderate im-
provement in activity performance or capacity (within the
context of the International Classification of Functioning,
Disability and Health (ICF) framework) occurs with
reductions in spasticity [6]. Reductions in spasticity are
associated with improvements on the Lindmark Motor
Assessment Scale [9], amount-of-use and quality-of-
movement scores of the Motor Activity Log [4], Goal
Attainment Scaling [10], and tasks such as hand hygiene
and dressing [11, 12]. In contrast, reductions in spasticity
have no effect on the Action Research Arm Test [4, 11] or
the Box and Block Test [4]. One possible factor contribut-
ing to the variability in these findings is that these out-
come measures are not constructed to characterize the
features of movement that contribute to the specific def-
icit. In contrast, robotic technologies may provide infor-
mation on the specific features of functional movement
that are impaired after stroke [13–17]. For example,
Bosecker, Dipietro, Volpe, and Krebs (2010), demon-
strated that performance on kinematic measures were pre-
dictors of clinical outcomes [18]. In addition, the Kinarm
robotic exoskeleton has been used as a probe of upper
limb function using a Visually Guided Reaching (VGR)
task to probe postural and motor control [16], an object
hit task to probe bimanual sensorimotor performance
[15], and a limb-position matching task to probe multi-
joint limb position sense [17]. Given the apparent sensitiv-
ity of these tasks to quantitatively measure impairment in
upper limb function and proproprioception after stroke,
they may also be useful in characterizing the features of
motor and proprioceptive impairment that are unique to
individuals with spasticity.
The objective of this study was to characterize the
features of kinematics and proprioception that are im-
paired in individuals with upper limb spasticity after
stroke using the Kinarm robotic exoskeleton. The two
tasks performed in the study were the VGR task and the
Arm Position Matching (APM) task. VGR was included
because it requires fast, co-ordinated reaching movements
to stationary targets, and thus is relevant to performance
of some everyday tasks. The APM task was used to assess
proprioception, which is integral for body image and plan-
ning motor actions. It was hypothesized that more severe
deficits in measures of movement kinematics and limb
proprioception would both be observed in post-stroke in-
dividuals with clinically-identified spasticity compared to
post-stroke individuals without spasticity.
Methods
Participants
Individuals with stroke were recruited from the Toronto
Rehabilitation Institute and Sunnybrook Health Sciences
Centre in Toronto, Canada, the inpatient acute stroke
unit and stroke rehabilitation units at Foothills Medical
Centre and the inpatient stroke rehabilitation units at
Dr. Vernon Fanning Care Centre in Calgary, Canada and
St. Mary’s on the Lake or Providence Care Hospital in
Kingston, Canada. Participants were included in the
study if they were over 18 years of age, had a confirmed
diagnosis of stroke, could understand the task instruc-
tions, were able to maintain a position of 90° shoulder
abduction with support, had normal or corrected vision,
and were able to participate in the informed consent
process. Individuals were excluded if the assessments
could be influenced by a pre-existing neurological condi-
tion, cognitive/behavioural issue, or a communication
limitation. All participants provided informed consent prior
to participation in the study. All procedures and methods
were approved by the ethics boards of the Toronto
Rehabilitation Institute, Sunnybrook Health Sciences
Centre, and the University of Toronto, the Queen’s
University Health Sciences and Affiliated Teaching
Hospitals Research Ethics Board (#ANAT042–05), and the
University of Calgary’s Conjoint Health Research Ethics
Board (#22123).
Presence of elbow spasticity was assessed by a
physiotherapist or a trained study investigator using
the Modified Ashworth Scale [19] (MAS ≥ 1 indicating
the presence of spasticity). The Chedoke McMaster
Stroke Assessment (CMSA, [20]) arm subscale was
implemented by a physical or occupational therapist
at the time of enrollment into the study. In some in-
stances, CMSA was retrospectively collected from the
participants’ admission to inpatient services and used
as an indicator of impairment. The CMSA uses a 7-
point scale reflecting stages of motor recovery follow-
ing stroke (7–highest recovery stage, 1–lowest recov-
ery). Affected side of stroke participants was
determined clinically as the most affected side of their
body. We refer to the other side of the body as the
“less-affected” side, as ~ 30% of individuals with
stroke experience impairment in the arm ipsilateral to
the lesioned hemisphere [16, 21].
Experimental setup
A detailed description of the Kinarm robotic exoskeleton
for the upper limb (Kinarm, Kingston, Canada) has been
presented previously [15–17]. The Kinarm robot collects
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shoulder and elbow kinematic information during tasks
performed in the horizontal plane and can apply loads
to move the arm in the workspace. Participants are
seated with shoulders abducted ~ 85° and arms resting
in troughs with full weight support of the limbs (Fig. 1a).
Linkages of the robot are aligned with the actual joints
of the participant. Calibration procedures were carried
out for each participant and included locating fingertip
position, defining a known elbow angle, and measuring
segment lengths for both arms. All tasks were controlled
and relayed using a real-time computer and Dexterit-E™
(versions 2.3.0–3.6.4) data acquisition software. During
each task, participants interact with a 2-D virtual reality
display unit where task objects appear on the same hori-
zontal plane as the participant’s arms.
Detailed descriptions of the tasks used in this study have
been reported previously. These include: Visually Guided
Reaching (VGR – 4 or 8 target version )[16] and Arm Pos-
ition Matching (APM – 4 or 9 target versions )[17]. The 4
target versions of the task were developed from the ori-
ginal 8 and 9 target versions to shorten the duration of the
task and use a subset of the original targets. During the
VGR task, the participant reached from a central target to
one of four or eight randomized peripheral targets as
quickly and accurately as possible (Fig. 1b). Each target
was presented five times for the four target version and
eight times for the eight target version of the reaching
task. VGR was assessed on both the affected and less-
affected limbs. During the APM task, vision of the limbs
was blocked and the robot moved the affected limb to one
of four or nine randomized positions in the workspace.
The participant was asked to mirror-match the position of
the limb with the opposite arm. Once the participant in-
formed the operator that the movement was completed
(i.e. they had perceived that they had matched the pos-
ition), the robot was prompted to move the limb to an-
other position in the workspace (Fig. 1c). This was
repeated until all four positions were attempted five times
for the four target version and six times for the nine target
version of the task. APM was assessed for the less-affected
limb only (i.e. robot moved the affected limb) to avoid the
issue of separating sensory and motor impairment if the
affected limb was required to position match (i.e. if the
robot moved the less-affected limb). The differences in
target location for the 4, 8, and 9 target versions are pre-
sented in Fig. 1d and e.
Outcome measures
The outcome measures from each task were selected be-
cause they represented different components of sensori-
motor control including speed, stability, smoothness, error
correction, and proprioception [16, 17]. In total, nine out-
come measures were used for the less-affected limb and six
measures were used for the affected limb. These included:
1. Visually Guided Reaching task (VGR)
a. Posture Speed (PS) – A descriptor of the
individual’s ability to keep the hand steady at
the central target. This was calculated as the
median hand speed for 500 ms prior to
presentation of the peripheral target. The
median of all trials is calculated as the overall
posture speed.
b. Initial Direction Angle (IDA) – Angular
deviation between a straight line from the
initial hand position and the hand position
after the initial phase of movement compared
to a straight line from the initial hand
position to the destination target. The initial
phase of movement is defined as the time
from movement onset to the first speed
minimum after movement onset. Movement
onset is identified by determining when the
hand first exits the start target after the end
target is illuminated and then searching back
in time to determine a point where the hand
speed dips below the maximum calculated
posture speed. If this point cannot be
determined using this algorithm, then
movement onset is set as the first time the
subject left the start target after illumination
of the end target.
c. Speed Maxima Count (SMC) – A measure of
smoothness determined by counting the
number of speed peaks from movement onset to
movement termination.
d. Movement Time (MT) – Time between
movement onset and movement termination.
This was included as a general descriptor of
movement.
e. Path Length Ratio (PLR) – A ratio of the
length of the total movement relative to the
length of a straight line between initial
position and target.
f. Maximum speed (MS) – Peak speed of the
movement.
2. Arm Position Matching task (APM)
a. Variability (Var) – an indicator of the trial-to-trial
consistency of the active hand. Variability was
calculated for each target location as the standard
deviations of the subject’s hand position in both the
X and Y directions (Varx and Vary). Variability XY
was calculated as follows:
Variability XY ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varx2 þ vary2
q
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b. Spatial Shift (Shift) – indicator of systematic errors
between the active and passive hands. This was
calculated as the mean error between the active and
passive hands for each target location, and then the
mean of means for all target locations. Systematic
shifts were calculated in the x (shiftx) and y (shifty)
directions. Combined shift in both x and y was
calculated as follows:
Shift XY ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
shiftx
2 þ shifty2
q
Fig. 1 a Diagram of the Kinarm robotic exoskeleton. Schematic representations of the tasks included in the present study, including: b Visually
Guided Reaching from a central fixation point to 4 randomly presented targets; c Arm Position Matching of one limb to one of 4 targets to
which the opposite limb is moved; d Schematic representation of the target locations for the 4 and 8 target Visually Guided Reaching task; e
Schematic representation of the target locations for the 4 and 9 target Arm Position Matching task. In d and e, the white circles depict the
targets included in the 8 or 9 versions only and the grey circles depict the targets included in both the 8/9 target and 4 target versions
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c. Contraction/Expansion ratio (Con/Exp XY) –
indicator of the area of the workspace comprising
the outer 4 or 8 targets ‘matched’ by the active
hand in comparison to that of the passive hand.
This was determined by calculating the area of
movement of the active hand and normalizing it by
the area covered by the passive hand.
Con=Exp XY ¼ areaxy active
areaxy passive
To compare parameters between groups, standardized
Z-scores were calculated for each parameter using
Dexterit-E software (Analysis Version 3.7). Parameter
scores were compared to a large cohort of healthy con-
trol data (VGR: N = 288 participants, 18–84 years old,
127 males; APM: 799 participants, 18–93 years old, 363
males) available through the Dexterit-E Analysis soft-
ware. Details of this process have been outlined previ-
ously [14, 22] and online (https://kinarm.com/kinarm-
products/kinarm-standard-tests). Briefly, control data
were normalized using Box-Cox transformations. The
data were fit using multiple linear regression (MLR) to
account for age, sex and handedness. Box-Cox equations
were adjusted if necessary to attain a normal distribution
and Z-scores were calculated for normal or transformed
to normal parameters. Z-scores were calculated for par-
ticipants with stroke using the same parameter models
developed from the healthy control participant data.
Standard cut-off scores were used to determine whether
performance of individual participants with stroke fell
outside of the normative bounds. For a one-sided com-
parison where a larger parameter value reflected poor
performance (i.e. posture speed) the cut-off of Z = 1.65
was used (95th percentile). For a one-sided comparison
where a smaller parameter value reflected poor perform-
ance (i.e. maximum speed) the cut-off of Z = − 1.65 was
used. For two-sided comparisons where either extreme
reflects poor performance (i.e. contraction/expansion ra-
tio) Z = 1.96 or − 1.96 cutoffs were used (2.5th, 97.5th
percentiles).
To further characterize performance on each task in
the context of healthy behaviour, ‘failure’ on each task
was determined by deriving the Task Score [22]. Briefly,
the Task Score is derived from a root sum of squares
(RSS) of all the healthy participant Z-score values for all
parameters from a given task. The RSS values are then
transformed to normal using Box-Cox equations [23]
and further transformed to a Task Score such that 0
equals best performance and poor performance is
reflected by higher values. Task Scores were calculated
for participants with stroke using the same parameter
models developed from the control participant data.
Because the Task Scores are based on Z-scores calcu-
lated relative to a healthy control dataset, a Task Score >
1.96 on for the VGR or APM reflects performance out-
side of the 95% confidence limit for healthy age-matched
individuals on that task. Therefore, this cutoff was used
to quantify the proportion of individuals failing each
task. Figure 2 depicts reaching trajectories and matching
ability for 2 representative participants (with and with-
out spasticity).
Statistical analyses
Descriptive statistics were used to characterize the study
groups: individuals with spasticity (Spasticity) and indi-
viduals without spasticity (No Spasticity). Wilcoxon rank
sum tests were used to determine whether individuals
with spasticity who were or were not taking anti-spastic
medication differed on any of the measures. Selected pa-
rameters from the robotic tasks were extracted from
standardized reports generated by the Dexterit-E soft-
ware. To test the hypothesis that individuals with spasti-
city would demonstrate greater deficits than individuals
without spasticity, Kolmogorov-Smirnov tests were used
to compare parameter Z-scores. Pearson’s Chi-Square
was used to determine whether the proportion of partic-
ipants in a group that failed a task (Task Score > 1.96)
differed from the proportion of participants who were
within normative bounds. Spearman’s correlations were
conducted to determine the level of association between
the MAS scores and parameter or task scores for the af-
fected limb (VGR task only) and less-affected limb (VGR
and APM tasks). Analyses were conducted using SPSS
v23 (IBM, Armonk, USA) and Matlab (Mathworks, Na-
tick, USA). The alpha level for statistical significance was
set at p ≤ 0.05 and all tests were corrected for multiple
comparisons using Bonferroni corrections. Adjusted p-
values are reported.
Results
A total of 70 individuals with stroke were included in the
study. Thirty five participants were included in each of the
Spasticity and No Spasticity groups. Critically, we matched
participants in terms of CMSA scores at the time of ad-
mission in an attempt to match the initial level of impair-
ment between the two groups (Table 1). All participants
with spasticity scored MAS ≥1 on the elbow flexors. Four
individuals with spasticity were being treated with anti-
spastic medication (baclofen, benzodiazapines). Seven
others were assessed at a time point > 90 days after focal
injection with onabotulinum toxin. A comparison of all
measures between all individuals with spasticity who were
(n = 11) or were not (n = 24) receiving anti-spastic medica-
tions revealed statistically significant differences in CMSA
(median CMSA= 4 and CMSA = 3, medication vs non-
medication, respectively; z = 2.54, p = 0.02) and Time post
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stroke (21months vs 6months, medication vs non-
medication, repsecitvely, z = 2.30, p = 0.01). No differences
were found between the medication vs non-medication
groups for any parameter Z-score or Task Score so data
were grouped. Demographics and clinical information for
all enrolled participants are presented in Table 1. Time
post-stroke denotes the time when the Kinarm assessment
was performed.
Fig. 2 Task Performance of two exemplar participants. a-c Participant from the No Spasticity group: Female, Right-handed, 70 years old, 7 months
post-stroke, Left-Affected, MAS of 0, CMSA arm (at intake) of 3. d-f Participant from the Spasticity group: Female, Right handed, 35 years old, 6
months post-stroke, Left-Affected, MAS of 1+, CMSA arm (at intake) of 3. a and d show the hand traces for the Visually Guided Reaching task.
Only the reaches out to the target are shown. B and E show the hand speeds for the reaches out to each target. Colour scheme matches the
traces in a and d. c and f reflect the performance on the Arm Position Matching task where the robot moved the affected left arm to four
locations (solid symbols – green line represents the perimeter of the targets) and the participant matched the position with the less-affected
right arm (open symbols - blue line represents the perimeter of the targets). Matching performance is mirrored and displayed over the left side
for comparison purposes. Ellipses around the icons reflect the spatial variability (1 standard deviation) of all matching trials at that target position.
Task Scores are shown below each (Task Score > 1.96 indicates that performance fell outside 95% range of healthy control behaviour)
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By observation, many participants in both groups dem-
onstrated deficits in both the VGR and APM tasks. For
the VGR tasks, these deficits were manifested as trajec-
tory errors, limitations in range of motion, movement
during intended periods of fixation on a target, and limi-
tations in target accuracy involving the affected arm. For
the APM tasks, the deficits were observed in the extent
of trial-to-trial variability, spatial shift, and area of the
workspace covered by the less-affected arm. Figure 2
presents exemplar performance data for both tasks for
individuals in both groups.
In general, a proportion of participants in each group
had deficits on each parameter (Fig. 3; Table 2). A higher
percentage of participants in the Spasticity group were
identified as impaired on almost every parameter tested
(except Path Length Ratio for VGR) compared to the No
Spasticity group. Direct comparisons of parameter distri-
butions identified statistically significant differences in
Movement Time (KS = 0.43, p-adj = 0.018) and Max-
imum Speed (KS = 0.40, p-adj = 0.045) (Fig. 3). There
were no differences between groups for APM task pa-
rameters (Fig. 3).
Based on the 95% confidence limits (Task Scores), a
proportion of participants failed each task. For the VGR
task with the affected limb, 76 and 50% of individuals in
the Spasicity and No Spasticity groups, respectively,
failed the task. These proportions were 24 and 18% for
the same groups with the less-affected limb. The Chi-
square analysis revealed statistically significant differ-
ences in the proportion of individuals failing the VGR-
affected limb between groups (χ2(1) = 5.044, p = 0.025).
No statistically significant difference in proportion was
observed for the VGR-less affected (χ2(1) = 2.365, p =
0.124). For APM, the proportion of individuals in the
Spasicity and No Spasticity groups failing the task with
the affected limb was 41 and 24%, respectively. The Chi-
square analysis revealed no statistically significant differ-
ences in the proportion of individuals failing the APM
task (χ2(1) = 0.0899, p = 0.7642).
Spearman’s correlation coefficients were generated to
quantify the strength of association between each of the
outcome measures and MAS assessed for the flexors
(Fig. 4). This analysis identified modest but statistically
significant correlations between MAS and Movement
Time (r = 0.33, p-adj = 0.038), Maximum Speed (r = −
0.38, p-adj = 0.009) and VGR Task Score (r = 0.34, p-
adj = 0.028).
Discussion
The objective of this study was to characterize the
features of movement kinematics and proproprioception
that are impaired in individuals with upper limb spasti-
city after stroke, when controlling for the initial level of
impairment. The analyses identified that individuals with
spasticity demonstrate greater deficits in features of
motor function related to movement time and move-
ment speed, as well as an overall metric of motor func-
tion. These measures were also associated with
spasticity. In contrast, although a higher proportion of
people with stroke (with or without spasticity) demon-
strated deficits in proprioception compared to estab-
lished normative values, none of the measures of
proprioception differed between groups. The findings
provide evidence indicating that specific features of
motor control, especially those associated with temporal
features of movement tend to be more impaired in indi-
viduals with upper limb spasticity after stroke.
Visually guided reaching – errors in temporal features of
motor function
Individuals with spasticity demonstrated greater deficits in
outcome measures for the VGR task measuring the tem-
poral features of movement. In addition, MAS was low-
to-moderately correlated with the same two outcome
measures. These findings point to the presence of spasti-
city as being associated with deficits in features of upper
limb motor control related to movement timing. The im-
portant clinical consideration here is that, in the context
of these motor assessments, spasticity is linked to the time
Table 1 Participant Information
No
Spasticity
(N = 35)
Spasticity
(N = 35)
Age (years)a 62.8 (27–87) 56.5 (18–78)
Sex (M/F) 25/10 24/11
Handedness
pre-stroke (L/R/A)
3/31/1 3/32/0
Affected side
of body (L/R)
16/19 20/15
Time post stroke
(months)a
6.28 (1–14.5) 14.73 (2–154)
Time to intake
(days)a
13.7 (4–34) 19.7 (2–39)
CMSA affected
arm (at intake)b
3 (2–5) 3 (2–5)
Scores: [2 3 4 5] [2 3 4 5]
# of
participants:
[4 11 15 5] [4 11 15 5]
MAS (flexors, at
time of robotic
assessment)b
0 1.5 (1–3)
Scores: [1 1+ 2 3]
# of
participants:
[13 10 9 3]
Abbreviations: MAS Modified Ashworth Scale, CMSA Chedoke-McMaster Stroke
Assessment (arm), adata presented as mean (range); bdata presented as
median (range). The median MAS score of 1.5 represents an actual score of 1+.
Time to intake refers to the amount of time between the stroke and CMSA
testing, which was completed at their intake into clinic
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required to perform a task and the speed at which a task
can be performed. The present findings align with prior
work demonstrating that movement time [24] and speed
are associated with the presence and/or severity of spasti-
city and that peak movement speed is lower in individuals
with spasticity prior to the onset of spasticity management
with botulinum toxin in comparison to healthy controls
[4]. Individuals with spasticity demonstrate an ability to
increase reaching speed [25]; however, to be able to do
this, compensatory strategies are used (i.e. increased trunk
motion if the trunk is unconstrained). In the current
experiment, the exoskeleton would have limited the oc-
currences of compensatory movements. As a result, indi-
viduals with spasticity would have relied on their existing
capacity for movement at the shoulder and elbow in the
absence of assistance from compensatory strategies. Con-
sequently, the challenge of overcoming higher flexor tone
may have induced impediments in both the time required
to perform the task and the speed at which the task could
be performed.
Slowing of movement may also reflect a learned strat-
egy to maximize task performance as motor learning
Fig. 3 CUSUM (Cumulative Sum) plots for each outcome measure demonstrating the proportion of individuals from the Spasticity group (dashed
lines) and the No Spasticity group (solid lines) who fail each task. A ‘fail’ is counted as a score exceeding the upper bound of the 95% limit of the
range of normal healthy controls (dashed vertical line). A ‘fail’ on Contraction/Expansion XY was a score above or below the 95% limit of the
range of normal healthy controls. The output from the Kolmogorov-Smirnov tests and adjusted p values are presented on each panel
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capacity persists in individuals with stroke [26]. How-
ever, Subramanian, Feldman, and Levin [27] reported
that spasticity may hinder motor learning capacity after
stroke, especially if the angular position of the elbow
while learning the task is within a spatial ‘spasticity zone’
– the angular range within which spasticity is observed.
The larger deficits in temporal metrics observed in our
spastic cohort may have occurred at elbow positions that
were within the range of the spastic zone. Deficits in
inter-joint coordination [24] (i.e. between shoulder and
elbow) in the spastic cohort may also contribute to
greater detriments in movement time and movement
speed. The VGR task would have engaged different
ranges of shoulder and elbow angles at each of the
targets.
It should be noted that the findings of the present
study parallel those of Otaka and colleagues [28], who
quantified relationships between outcome measures on
the visually guided reach task on the Kinarm with clin-
ical outcomes, including the MAS. Both papers report
low-to-moderate correlations between Kinarm outcomes
and the MAS; however, Otaka’s group identified statisti-
cally significant correlations of varying strength with
VGR outcomes other than those reported here. Differ-
ences in the proportion of individuals with MAS = 0 be-
tween studies (35/70 in the current study, 10/56 in
Otaka et al.) could account for these differences.
Global versus domain-specific deficits in motor function
It is also important to note that the proportion of partic-
ipants with a “failing” VGR Task Score was higher in the
spasticity group and that Task Score was significantly
(although modestly) associated with MAS. The Task
Score represents a cumulative metric of motor impair-
ment rather than a specific component of impairment.
From this perspective, the present findings indicate that
individuals with spasticity demonstrate deficits in move-
ment kinematics. In the context of the individual-
parameter findings, it may be that movement time and
movement speed are among the more important features
of motor output in spasticity or that time and speed are
important elements of all the tasks included in the as-
sessment. Alternatively, the present findings can also be
interpreted as support for previously-reported findings
indicating that the MAS does not correlate well with
kinematic measures [18] or that spasticity and paresis
have different impacts on motor function [28]. Another
possibility is that there are features of control unique to
spasticity that are not captured in the individual do-
mains included in the VGR task.
Deficits in proprioception were not more evident in
individuals with spasticity
Interestingly, no statistically significant relationships be-
tween MAS and APM outcomes were observed, nor
were differences between groups observed for any of the
APM outcomes. All of the kinematic data for the APM
task were derived by having the affected limb passively
moved to the targets, requiring the less-affected limb to
position match. This specific component of testing was
implemented to overcome the obvious issue of having
the robot passively move the less-affected limb and then
Table 2 Parameter scores, Z scores, Task scores, and the proportion of participants from each group failing each parameter. A ‘fail’ is
identified as a score falling outside of the 95% Confidence Interval of healthy controls
Parameter data (median, range) Z-score (median) & Task score (mean) Proportion failed (%)
Parameter No Spasticity Spasticity No Spasticity Spasticity No Spasticity Spasticity
VGR
Posture Speed (m/s) 0.005 (0.003–0.018) 0.005 (0.001–0.026) 0.53 0.82 29 32
Initial Direction Angle (rad) 0.069 (0.037–0.211) 0.07 (0.033–1.20) 1.77 1.93 62 65
Speed Maxima Count 2.56 (1.65–4.46) 2.83 (1.97–11) 0.58 1.16 32 41
Movement time (s) 1.11 (0.70–1.72) 1.27 (0.96–4.20) 0.59 1.32 24 44
Path Length Ratio 1.22 (1.06–1.74) 1.22 (1.06–2.92) 1.70 1.5 53 47
Max Speed (m/s) 0.24 (0.14–0.32) 0.21 (0.13–0.33) −0.09 − 0.61 3 21
VGR-affected Task Score – – 2.09 3.07 50 76
VGR-less affected Task Score – – 0.91 1.30 18 24
APM
Variability XY (m) 0.036 (0.023–0.13) 0.041 (0.021–0.11) 0.09 0.93 29 38
Shift XY (m) 0.053 (0.007–0.172) 0.058 (0.007–0.15) 0.50 0.71 9 15
Con/Exp XY 0.67 (0.047–1.25) 0.841 (0.036–1.40) −0.72 −0.37 18 29
APM Task Score – – 1.49 1.78 24 41
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Fig. 4 Scatterplots showing the relationship between MAS score and each outcome measure (including Task Scores) for the Visually Guided
Reaching and Arm Position Matching tasks. Spearman’s r and the adjusted p value for each correlation are presented on each graph. Lines of
best fit are included on those graphs in which a statistically significant correlation between outcome measure and MAS was observed
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trying to determine whether affected limb matching was
poor due to proprioceptive or motoric deficits. In so
doing, it was expected that deficits in proprioception
would be observed and associated with clinical measures
of spasticity.
We note that these findings should not be interpreted
as indicating that proprioceptive deficits do not exist in
the Spasticity group. In comparison to the healthy nor-
mative data, deficits were observed in both motor and
proprioception tasks indicating that individuals with
stroke have proprioceptive deficits, irrespective of the
presence of spasticity. The present findings simply indi-
cate that the deficits of the individuals with spasticity
were not necessarily more impactful than the deficits of
those without spasticity. From a more general perspec-
tive, the observation that a proportion of participants
from both groups failed parameters and tasks in both
the VGR and APM tasks (Table 2) implies that rather
than being purely motoric in nature, deficits in move-
ment control after stroke are also linked to deficits in
proprioception. This position is in line with the findings
of Dukelow and colleagues [29], who suggested that both
motor and proprioceptive deficits are present after
stroke, even though they are statistically independent
from each other.
Again, the idea of a spasticity zone [27] may explain
why proprioception deficits were not observed. In this
case, the locations to which the affected limb was pas-
sively moved may not have required elbow angular
ranges within which spasticity occurred. However, given
the observation that participants in the spasticity group
were assessed as MAS = 2 or 3, resistance to passive
movement would have been detected through most of
the range of motion and within workspace covered by
the APM task. It is important to consider that the APM
task only characterized one component of propriocep-
tion – position sense. Other features like kinesthesia
(sense of limb motion) or sense of effort also reflect pro-
prioception, but these were not included in the current
study. It is possible that although spasticity and position
sense are independent from each other, other compo-
nents of proprioprioception may be more related to
spasticity [30].
Limitations
One measure that is not included here, but which may be
a confounder to motor output in spasticity [31, 32] is
muscle strength. Because the planar movements that com-
prise the present study are performed with the limbs sup-
ported and because the overall range of movement is
relatively small, the potential contribution of impaired
strength may be somewhat mitigated. However, strength
should be taken into consideration in further understand-
ing the factors that impact motor control in individuals
with spasticity. In addition, the only sensory modality that
was examined in the present study was proprioception.
Recent work has identified kinesthesia as also being im-
paired after stroke [33, 34]. Kinesthetic deficits may also
be a greater determinant of motor function in individuals
with post-stroke spasticity or may be more indicative of
the types of sensory deficits that occur with spasticity.
Other methodological limitations include the absence
of direct measures of proprioception, assessment of
spasticity using only one clinical scale, and that we did
not record electromyographic activity of muscle during
movement. Such direct measures would have provided a
more complete characterization of the study cohort and
a clearer picture of the existing proprioceptive and
muscle state. However the focus of this work was on the
kinematic comparison.
One methodological limitation related to recruitment
is that only part of the Spasticity cohort were assessed
for elbow extensor spasticity. Five individuals with spas-
ticity of both the flexors and extensors were included to
balance the group sample sizes to as great an extent as
possible. Extensor spasticity was also not assessed on all
participants in the No Spasticity group. Thus, it is pos-
sible that individuals in the No Spasticity group may
have had extensor spasticity, which would have impacted
the ability to observe larger differences between groups.
The findings could have been more robust with a more
homogeneous spastic cohort. This also applies to the
possible limitation of the timing of administration of
spasticity management interventions at the time of as-
sessment and the extent to which these interventions
impacted the ability to identify differences between
groups.
Conclusions
Individuals with and without upper limb spasticity dem-
onstrate deficits in both movement kinematics and pro-
prioception, even months-to-years after their stroke;
however, only kinematic deficits are greater in individ-
uals with spasticity. More specifically, measures charac-
terizing temporal features of movement and global
measures of movement deficits are most impacted and
are also correlated with clinical scores of spasticity
(MAS). This work contributes to the growing body of
literature characterizing the impact of upper limb spasti-
city on motor control.
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